PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation

•CAST regimen is safe and effective in reducing acute GVHD after haploidentical peripheral blood transplantation.•Our outcomes provide an impetus to further examine this novel combination in GVHD prevention. [Display omitted] Reducing the incidence of graft-versus-host disease (GVHD) after haploiden...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood advances 2023-07, Vol.7 (14), p.3604-3611
Hauptverfasser:	Al-Homsi, A. Samer, Cirrone, Frank, Wo, Stephanie, Cole, Kelli, Suarez-Londono, J. Andres, Gardner, Sharon L., Hsu, Jingmei, Stocker, Kelsey, Bruno, Benedetto, Goldberg, Judith D., Levinson, Benjamin A., Abdul-Hay, Maher
Format:	Artikel
Sprache:	eng
Schlagworte:	Abatacept - therapeutic use Adolescent Adult Aged Cyclophosphamide - therapeutic use Graft vs Host Disease - drug therapy Graft vs Host Disease - etiology Graft vs Host Disease - prevention & control Humans Middle Aged Tacrolimus - therapeutic use Transplantation Transplantation, Haploidentical Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!